a 68930 has been researched along with Seizures in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asin, KE; Britton, DR; DeNinno, MP; Kebabian, JW; MacKenzie, R; Schoenleber, R | 1 |
| Ackerman, M; Artman, L; Asin, KE; Bednarz, L; Briggs, C; Britton, DR; DeNinno, MP; MacKenzie, R; Schoenleber, R; Trugman, JM | 1 |
2 other study(ies) available for a 68930 and Seizures
| Article | Year |
|---|---|
A68930: a potent agonist specific for the dopamine D1 receptor.
Topics: Adenylyl Cyclases; Animals; Behavior, Animal; Carps; Caudate Nucleus; Chromans; Dopamine Agonists; Enzyme Activation; Putamen; Rats; Receptors, Dopamine D1; Retina; Seizures | 1992 |
A68930: a potent agonist selective for the dopamine D1 receptor.
Topics: Adenylyl Cyclases; Animals; Benzazepines; Binding Sites; Carps; Chromans; Deoxyglucose; Dopamine Agents; Haloperidol; Male; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Dopamine D1; Seizures; Substantia Nigra; Tumor Cells, Cultured | 1991 |